Expression of ligands to NKp46 in benign and malignant melanocytes

Journal of Investigative Dermatology

Volumn 128, Issue 4, 2008, Pages 972-979

  Cagnano, Emanuela ^a   Hershkovitz, Oren ^b   Zilka, Alon ^b   Bar Ilan, Ahuva ^b   Golder, Alexandra ^b   Sion Vardy, Netta ^a   Bogdanov Berezovsky, Alexander ^a   Mandelboim, Ofer ^c   Benharroch, Daniel ^a   Porgador, Angel ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN FC FRAGMENT; LIGAND;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMIS; DERMOEPIDERMAL JUNCTION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MELANOCYTE; MELANOMA; NATURAL KILLER CELL; NEVUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 40649094808     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701111     Document Type: Article

References (30)

1. T.I. Arnon H. Achdout N. Lieberman R. Gazit T. Gonen-Gross G. Katz The mechanisms controlling the recognition of tumor and virus infected cells by NKp46 Blood 103 2004 664 672
2. T.I. Arnon M. Lev G. Katz Y. Chernobrov A. Porgador O. Mandelboim Recognition of viral hemagglutinins by NKp44 but not by NKp30 Eur J Immunol 31 2001 2680 2689
3. A.B. Bakker J. Wu J.H. Phillips L.L. Lanier NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals Hum Immunol 61 2000 18 27
4. R. Biassoni C. Cantoni D. Pende S. Sivori S. Parolini M. Vitale Human natural killer cell receptors and co-receptors Immunol Rev 181 2001 203 214
5. N. Bloushtain U. Qimron A. Bar-Ilan O. Hershkovitz R. Gazit E. Fima Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46 J Immunol 173 2004 2392 2401
6. A. Cerwenka A.B. Bakker T. McClanahan J. Wagner J. Wu J.H. Phillips Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice Immunity 12 2000 721 727
7. G.P. Dunn A.T. Bruce H. Ikeda L.J. Old R.D. Schreiber Cancer immunoediting: from immunosurveillance to tumor escape Nat Immunol 3 2002 991 998
8. A. Garg P.F. Barnes A. Porgador S. Roy S. Wu J.S. Nanda Vimentin expressed on Mycobacterium tuberculosis -infected human monocytes is involved in binding to the NKp46 receptor J Immunol 177 2006 6192 6198
9. P.B. Gupta C. Kuperwasser J.P. Brunet S. Ramaswamy W.L. Kuo J.W. Gray The melanocyte differentiation program predisposes to metastasis after neoplastic transformation Nat Genet 37 2005 1047 1054
10. O. Hershkovitz S. Jivov N. Bloushtain A. Zilka G. Landau A. Bar-Ilan Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44 Biochemistry 46 2007 7426 7436
11. K. Karre NK cells, MHC class I molecules and the missing self Scand J Immunol 55 2002 221 228
12. M.J. Kornstein R. Stewart D.E. Elder Natural killer cells in the host response to melanoma Cancer Res 47 1987 1411 1412
13. O. Mandelboim A. Porgador NKp46 Int J Biochem Cell Biol 33 2001 1147 1150
14. O. Mandelboim N. Lieberman M. Lev L. Paul T.I. Arnon Y. Bushkin Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells Nature 409 2001 1055 1060
15. E. Mavoungou J. Held L. Mewono P.G. Kremsner A duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum -parasitized erythrocytes by natural killer cells J Infect Dis 195 2007 1521 1531
16. K.L. McQueen P. Parham Variable receptors controlling activation and inhibition of NK cells Curr Opin Immunol 14 2002 615 621
17. A. Moretta R. Biassoni C. Bottino M.C. Mingari L. Moretta Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis Immunol Today 21 2000 228 234
18. A. Moretta C. Bottino M. Vitale D. Pende C. Cantoni M.C. Mingari Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis Annu Rev Immunol 19 2001 197 223
19. L. Moretta A. Moretta Unravelling natural killer cell function: triggering and inhibitory human NK receptors EMBO J 23 2004 255 259
20. L. Moretta C. Bottino D. Pende M. Vitale M.C. Mingari A. Moretta Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis Immunol Lett 100 2005 7 13
21. M.M. Mueller N.E. Fusenig Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells Differentiation 70 2002 486 497
22. E.N. Nolte-'t Hoen C.R. Almeida N.R. Cohen S. Nedvetzki H. Yarwood D.M. Davis Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication Blood 109 2007 670 673
23. D. Pende P. Rivera S. Marcenaro C.C. Chang R. Biassoni R. Conte Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity Cancer Res 62 2002 6178 6186
24. A. Poggi A.M. Massaro S. Negrini P. Contini M.R. Zocchi Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors J Immunol 174 2005 2653 2660
25. A. Porgador O. Mandelboim N.P. Restifo J.L. Strominger Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy Proc Natl Acad Sci USA 94 1997 13140 13145
26. R. Puches J. Smolle E. Rieger H.P. Soyer H. Kerl Expression of cytoskeletal components in melanocytic skin lesions. An immunohistochemical study Am J Dermatopathol 13 1991 137 144
27. T.F. Smetsers E.M. van de Westerlo G.B. ten Dam R. Clarijs E.M. Versteeg W.L. van Geloof Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma Cancer Res 63 2003 2965 2970
28. C.S. Vetter P.T. Straten P. Terheyden J. Zeuthen E.B. Brocker J.C. Becker Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma J Invest Dermatol 114 2000 941 947
29. M.R. Wick J.W. Patterson Cutaneous melanocytic lesions: selected problem areas Am J Clin Pathol 124 Suppl 2005 S52 S83
30. A. Zilka G. Landau O. Hershkovitz N. Bloushtain A. Bar-Ilan F. Benchetrit Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46 Biochemistry 44 2005 14477 14485